Exicure, Inc. is a clinical-stage biotechnology company based in Chicago, Illinois, focusing on the development of novel therapies through its proprietary spherical nucleic acid (SNA) technology. With a robust pipeline targeting neurological disorders, immuno-oncology, inflammatory diseases, and genetic disorders, Exicure aims to revolutionize treatment approaches and enhance the efficacy of RNA-based medicine. The company's innovative platform positions it as a key player in the biopharmaceutical sector, with the potential to address unmet medical needs and transform patient care across multiple therapeutic areas. Show more
Location: 400 SEAPORT COURT, REDWOOD CITY, CA, UNITED STATES, 94063, Redwood City, CA, 94063, USA | Website: https://www.exicuretx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
25.94M
52 Wk Range
$3.10 - $15.91
Previous Close
$4.07
Open
$4.24
Volume
10,664
Day Range
$4.07 - $4.31
Enterprise Value
21.87M
Cash
4.438M
Avg Qtr Burn
-3.528M
Insider Ownership
35.38%
Institutional Own.
5.72%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Burixafor Details Multiple myeloma | Phase 2 Update |
